Kinetics of chloral hydrate and its metabolites in male human volunteers.
Chloral hydrate (CH) is a short-lived intermediate in the metabolism of trichloroethylene (TRI). TRI, CH, and two common metabolites, trichloroacetic acid (TCA) and dichloroacetic acid (DCA) have been shown to be hepatocarcinogenic in mice. To better understand the pharmacokinetics of these metabolites of TRI in humans, eight male volunteers, aged 24-39, were administered single doses of 500 or 1,500 mg or a series of three doses of 500 mg given at 48 h intervals, in three separate experiments. Blood and urine were collected over a 7-day period and CH, DCA, TCA, free trichloroethanol (f-TCE), and total trichloroethanol (T-TCE=trichloroethanol and trichloroethanol-glucuronide [TCE-G]) were measured. DCA was detected in blood and urine only in trace quantities (<2 microM). TCA, on the other hand, had the highest plasma concentration and the largest AUC of any metabolite. The TCA elimination curve displayed an unusual concentration-time profile that contained three distinct compartments within the 7-day follow-up period. Previous work in rats has shown that the complex elimination curve for TCA results largely from the enterohepatic circulation of TCE-G and its subsequent conversion to TCA. As a result TCA had a very long residence time and this, in turn, led to a substantial enhancement of peak concentrations following the third dose in the multiple dose experiment. Approximately 59% of the AUC of plasma TCA following CH administration is produced via the enterohepatic circulation of TCE-G. The AUC for f-TCE was found to be positively correlated with serum bilirubin concentrations. This effect was greatest in one subject that was found to have serum bilirubin concentrations at the upper limit of the normal range in all three experiments. The AUC of f-TCE in the plasma of this individual was consistently about twice that of the other seven subjects. The kinetics of the other metabolites of CH was not significantly modified in this individual. These data indicate that individuals with a more impaired capacity for glucuronidation may be very sensitive to the central nervous system depressant effects of high doses of CH, which are commonly attributed to plasma levels of f-TCE.
Merdink
J L
JL
Pharmacology/Toxicology, Washington State University, Pullman, WA, United States.
Robison
L M
LM
Stevens
D K
DK
Hu
M
M
Parker
J C
JC
Bull
R J
RJ
D000328:Adult; D002697:Chloral Hydrate / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics* / Q000652:urine; D003999:Dichloroacetic Acid / Q000097:blood / Q000378:metabolism / Q000652:urine; D005023:Ethylene Chlorohydrin / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism / Q000652:urine; D005965:Glucuronates / Q000097:blood / Q000378:metabolism / Q000652:urine; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014238:Trichloroacetic Acid / Q000097:blood / Q000378:metabolism / Q000652:urine
D005965:Glucuronates; C405204:trichloroethanol glucuronide; D002697:Chloral Hydrate; D014238:Trichloroacetic Acid; D005023:Ethylene Chlorohydrin; D003999:Dichloroacetic Acid; C005849:2,2,2-trichloroethanol